NHS to offer second MenB vaccine after deadly Kent outbreak

NHS to Offer Second MenB Vaccine After Kent Outbreak

Following a meningitis B outbreak in Kent, nearly 12,000 individuals who received initial vaccinations will now have access to a second dose starting next week. The campaign targets those exposed to the disease, such as university students and school pupils in the region. Health officials emphasized that two doses are necessary for full protection.

The National Health Service (NHS) has expanded its efforts, with clinics launching in Canterbury, Faversham, and Ashford. Eligible participants can book appointments through an online system. Those at higher risk include students residing in Kent university halls and attendees of a nightclub linked to the outbreak. NHS Kent and Medway confirmed appointments will be available at multiple sites, with booking details to be released on Monday.

Outbreak Impact and Response

Two fatalities and 19 confirmed cases have emerged from the outbreak. The UK Health Security Agency (UKHSA) declared a national incident to streamline resource allocation, including antibiotic distribution. Initially, the vaccination drive focused on students in university residences before broadening to include patrons of Club Chemistry, where the outbreak originated.

“This outbreak is unprecedented due to the rapid spread of infection,” stated Health Secretary Wes Streeting. The remark highlights the urgency of the situation, as the disease affected numerous people in a brief period.

Additional groups, such as sixth form students at schools with confirmed cases, were later added to the program. Preventative antibiotics were distributed to a larger population, with long lines forming at the University of Kent over several days.

Historical Vaccination Context

A routine MenB vaccination program began in the UK in 2015, targeting infants and young children. At that time, UK advisers deemed a catch-up campaign for teenagers economically inefficient. As a result, teenagers received the MenACWY vaccine instead, which covers four bacterial strains but not MenB.

The recent outbreak prompted Streeting to commission a review by independent experts at the Joint Committee on Vaccination and Immunisation (JCVI). The decision to re-evaluate teenage vaccination protocols underscores the evolving public health strategy in response to the crisis.